Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T15:35:38.257Z.
Calculation as of: 2026-10-06T15:35:38.257Z.
Quote observation: 2026-10-06T15:35:03.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 47b7d046e53ba400f53df530976eb059ace8f079140d97e9bcfa36b682aba175
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2025-03-20.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
EV/FCF RATIO AVG TTM
2.71x
EV/FCF RATIO AVG 3Y
2.71x
EV/FCF RATIO AVG 5Y
2.71x
EV/FCF RATIO AVG 10Y
N/A
EV/FCF RATIO AVG 15Y
N/A
EV/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Assembly Biosciences, Inc.
Market Cap
$444.80M
EV/FCF Ratio
N/A
TTM Avg
2.71x
3Y Avg
2.71x
5Y Avg
2.71x
Market Cap
$450.00M
EV/FCF Ratio
N/A
TTM Avg
25.38x
3Y Avg
25.38x
5Y Avg
25.38x
Market Cap
$439.67M
EV/FCF Ratio
N/A
TTM Avg
43.72x
3Y Avg
43.72x
5Y Avg
43.72x
Market Cap
$454.47M
EV/FCF Ratio
N/A
TTM Avg
0.21x
3Y Avg
0.21x
5Y Avg
0.21x
Market Cap
$425.48M
EV/FCF Ratio
N/A
TTM Avg
32.08x
3Y Avg
32.08x
5Y Avg
32.08x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Assembly Biosciences, Inc. (ASMB) | $444.80M | N/A | 2.71x | 2.71x | 2.71x |
| NeuroPace, Inc. (NPCE)vs › | $442.61M | N/A | N/A | N/A | N/A |
| Capricor Therapeutics, Inc. (CAPR)vs › | $450.00M | N/A | 25.38x | 25.38x | 25.38x |
| Editas Medicine, Inc. (EDIT)vs › | $439.67M | N/A | 43.72x | 43.72x | 43.72x |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $452.89M | N/A | N/A | N/A | N/A |
| Ovid Therapeutics Inc. (OVID)vs › | $454.47M | N/A | 0.21x | 0.21x | 0.21x |
| NeoGenomics, Inc. (NEO)vs › | $434.25M | N/A | 51.06x | 46.23x | 33.62x |
| NRC Health (NRC)vs › | $461.38M | 25.33x | 32.87x | 32.01x | 32.13x |
| Prothena Corporation plc (PRTA)vs › | $425.48M | N/A | 32.08x | 32.08x | 32.08x |
| Kamada Ltd. (KMDA)vs › | $467.32M | 16.98x | 21.93x | 76.52x | 57.94x |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/FCF RATIO |
|---|---|
| 2025-03-20 | 1.79x |
| 2025-03-19 | 1.83x |
| 2025-03-18 | 1.95x |
| 2025-03-17 | 1.76x |
| 2025-03-14 | 1.84x |
| 2025-03-13 | 1.77x |
| 2025-03-12 | 1.89x |
| 2025-03-11 | 1.82x |
| 2025-03-10 | 1.92x |
| 2025-03-07 | 1.91x |
| 2025-03-06 | 2.00x |
| 2025-03-05 | 2.15x |
| 2025-03-04 | 2.14x |
| 2025-03-03 | 2.22x |
| 2025-02-28 | 2.40x |
| 2025-02-27 | 2.42x |
| 2025-02-26 | 2.52x |
| 2025-02-25 | 2.25x |
| 2025-02-24 | 2.31x |
| 2025-02-21 | 2.25x |
| 2025-02-20 | 2.36x |
| 2025-02-19 | 2.36x |
| 2025-02-18 | 2.29x |
| 2025-02-14 | 2.44x |
| 2025-02-13 | 2.21x |
| 2025-02-12 | 2.31x |
| 2025-02-11 | 2.47x |
| 2025-02-10 | 2.62x |
| 2025-02-07 | 2.51x |
| 2025-02-06 | 2.62x |
| 2025-02-05 | 2.77x |
| 2025-02-04 | 2.66x |
| 2025-02-03 | 2.66x |
| 2025-01-31 | 2.71x |
| 2025-01-30 | 2.83x |
| 2025-01-29 | 2.67x |
| 2025-01-28 | 2.84x |
| 2025-01-27 | 2.73x |
| 2025-01-24 | 2.92x |
| 2025-01-23 | 2.95x |
| 2025-01-22 | 2.98x |
| 2025-01-21 | 2.79x |
| 2025-01-17 | 2.85x |
| 2025-01-16 | 2.83x |
| 2025-01-15 | 2.85x |
| 2025-01-14 | 2.92x |
| 2025-01-13 | 2.96x |
| 2025-01-10 | 3.16x |
| 2025-01-08 | 3.53x |
| 2025-01-07 | 3.65x |
| 2025-01-06 | 3.64x |
| 2025-01-03 | 3.68x |
| 2025-01-02 | 3.59x |
| 2024-12-31 | 3.21x |
| 2024-12-30 | 3.28x |
| 2024-12-27 | 3.03x |
| 2024-12-26 | 3.09x |
| 2024-12-24 | 2.91x |
| 2024-12-23 | 2.97x |
| 2024-12-20 | 3.05x |
| 2024-12-19 | 3.21x |
| 2024-12-18 | 2.57x |
| 2024-12-17 | 2.79x |
| 2024-12-16 | 3.14x |
| 2024-12-13 | 3.09x |
| 2024-12-12 | 3.09x |
| 2024-12-11 | 3.01x |
| 2024-12-10 | 3.30x |
| 2024-12-09 | 3.46x |
| 2024-12-06 | 3.28x |
| 2024-12-05 | 3.36x |
| 2024-12-04 | 3.35x |
| 2024-12-03 | 3.38x |
| 2024-12-02 | 3.48x |
| 2024-11-29 | 3.56x |
| 2024-11-27 | 3.50x |
| 2024-11-26 | 3.04x |
| 2024-11-25 | 2.94x |
| 2024-11-22 | 3.00x |
| 2024-11-21 | 2.91x |
| 2024-11-20 | 2.99x |
| 2024-11-19 | 3.08x |
| 2024-11-18 | 3.22x |
| 2024-11-15 | 3.31x |
| 2024-11-14 | 3.56x |
| 2024-11-13 | 3.46x |
| 2024-11-12 | 3.43x |
| 2024-11-11 | 3.38x |
| 2024-11-08 | 3.48x |
| 2024-11-07 | 3.37x |
| 2024-11-06 | 3.17x |
| 2024-11-05 | 3.15x |
| 2024-11-04 | 3.25x |
| 2024-11-01 | 3.23x |
| 2024-10-31 | 3.21x |
| 2024-10-30 | 3.26x |
| 2024-10-29 | 3.42x |
| 2024-10-28 | 3.21x |
| 2024-10-25 | 3.23x |
| 2024-10-24 | 3.24x |
| 2024-10-23 | 3.16x |
| 2024-10-22 | 3.21x |
| 2024-10-21 | 3.16x |
| 2024-10-18 | 3.55x |
| 2024-10-17 | 3.51x |
| 2024-10-16 | 3.39x |
| 2024-10-15 | 3.61x |
| 2024-10-14 | 3.26x |
| 2024-10-11 | 3.36x |
| 2024-10-10 | 3.03x |
| 2024-10-09 | 3.02x |
| 2024-10-08 | 2.65x |
| 2024-10-07 | 2.72x |
| 2024-10-04 | 2.76x |
| 2024-10-03 | 2.72x |
| 2024-10-02 | 2.71x |
| 2024-10-01 | 2.74x |
| 2024-09-30 | 2.82x |
| 2024-09-27 | 2.97x |
| 2024-09-26 | 2.92x |
| 2024-09-25 | 2.87x |
| 2024-09-24 | 2.82x |
| 2024-09-23 | 3.08x |
| 2024-09-20 | 3.83x |
| 2024-09-19 | 3.61x |
| 2024-09-18 | 3.53x |
| 2024-09-17 | 3.53x |
| 2024-09-16 | 3.57x |
| 2024-09-13 | 3.51x |
| 2024-09-12 | 3.50x |
| 2024-09-11 | 3.35x |
| 2024-09-10 | 3.20x |
| 2024-09-09 | 3.16x |
| 2024-09-06 | 3.25x |
| 2024-09-05 | 3.13x |
| 2024-09-04 | 3.16x |
| 2024-09-03 | 2.98x |
| 2024-08-30 | 3.08x |
| 2024-08-29 | 3.04x |
| 2024-08-28 | 3.20x |
| 2024-08-27 | 3.08x |
| 2024-08-26 | 2.99x |
| 2024-08-23 | 2.70x |
| 2024-08-22 | 2.65x |
| 2024-08-21 | 2.71x |
| 2024-08-20 | 2.67x |
| 2024-08-19 | 2.77x |
| 2024-08-16 | 2.62x |
| 2024-08-15 | 2.57x |
| 2024-08-14 | 2.56x |
| 2024-08-13 | 2.77x |
| 2024-08-12 | 2.34x |
| 2024-08-09 | 2.32x |
| 2024-08-08 | 2.05x |
| 2024-08-07 | 1.90x |
| 2024-08-06 | 2.05x |
| 2024-08-05 | 2.05x |
| 2024-08-02 | 2.23x |
| 2024-08-01 | 2.25x |
| 2024-07-31 | 2.30x |
| 2024-07-30 | 2.26x |
| 2024-07-29 | 2.28x |
| 2024-07-26 | 2.36x |
| 2024-07-25 | 2.34x |
| 2024-07-24 | 2.35x |
| 2024-07-23 | 2.42x |
| 2024-07-22 | 2.38x |
| 2024-07-19 | 2.40x |
| 2024-07-18 | 2.37x |
| 2024-07-17 | 2.40x |
| 2024-07-16 | 2.44x |
| 2024-07-15 | 2.45x |
| 2024-07-12 | 2.34x |
| 2024-07-11 | 2.24x |
| 2024-07-10 | 2.14x |
| 2024-07-09 | 2.13x |
| 2024-07-08 | 2.15x |
| 2024-07-05 | 2.02x |
| 2024-07-03 | 1.81x |
| 2024-07-02 | 2.05x |
| 2024-07-01 | 2.03x |
| 2024-06-28 | 2.12x |
| 2024-06-27 | 2.30x |
| 2024-06-26 | 2.24x |
| 2024-06-25 | 2.46x |
| 2024-06-24 | 2.52x |
| 2024-06-21 | 2.50x |
| 2024-06-20 | 2.44x |
| 2024-06-18 | 2.35x |
| 2024-06-17 | 2.41x |
| 2024-06-14 | 2.45x |
| 2024-06-13 | 2.40x |
| 2024-06-12 | 2.48x |
| 2024-06-11 | 2.46x |
| 2024-06-10 | 2.42x |
| 2024-06-07 | 2.23x |
| 2024-06-06 | 2.46x |
| 2024-06-05 | 2.44x |
| 2024-06-04 | 2.40x |
| 2024-06-03 | 2.37x |
| 2024-05-31 | 2.41x |
| 2024-05-30 | 2.35x |
| 2024-05-29 | 2.39x |
| 2024-05-28 | 2.39x |
| 2024-05-24 | 2.39x |
| 2024-05-23 | 2.33x |
| 2024-05-22 | 2.40x |
| 2024-05-21 | 2.41x |
| 2024-05-20 | 2.37x |
| 2024-05-17 | 2.28x |
| 2024-05-16 | 2.32x |
| 2024-05-15 | 2.30x |
| 2024-05-14 | 2.16x |
| 2024-05-13 | 2.06x |
| 2024-05-10 | 2.06x |
| 2024-05-09 | 1.98x |
| 2024-05-08 | 2.35x |
| 2024-05-07 | 2.30x |
| 2024-05-06 | 2.35x |
| 2024-05-03 | 2.43x |
| 2024-05-02 | 2.35x |
| 2024-05-01 | 2.46x |
| 2024-04-30 | 2.26x |
| 2024-04-29 | 2.37x |
| 2024-04-26 | 2.31x |
| 2024-04-25 | 2.48x |
| 2024-04-24 | 2.51x |
| 2024-04-23 | 2.46x |
| 2024-04-22 | 2.45x |
| 2024-04-19 | 2.49x |
| 2024-04-18 | 2.47x |
| 2024-04-17 | 2.37x |
| 2024-04-16 | 2.76x |
| 2024-04-15 | 2.86x |
| 2024-04-12 | 2.79x |
| 2024-04-11 | 2.89x |
| 2024-04-10 | 2.80x |
| 2024-04-09 | 2.84x |
| 2024-04-08 | 2.73x |
| 2024-04-05 | 2.58x |
| 2024-04-04 | 2.55x |
| 2024-04-03 | 2.58x |
| 2024-04-02 | 2.51x |
| 2024-04-01 | 2.37x |
| 2018-05-07 | 997.38x |
| 2018-05-04 | 1012.99x |
| 2018-05-03 | 970.31x |
| 2018-05-02 | 1012.99x |
| 2018-05-01 | 1003.72x |
| 2018-04-30 | 977.87x |
| 2018-04-27 | 1038.59x |
| 2018-04-26 | 1001.52x |
| 2018-04-25 | 983.48x |
| 2018-04-24 | 981.04x |
| 2018-04-23 | 986.41x |
| 2018-04-20 | 1057.61x |
| 2018-04-19 | 1052.25x |
| 2018-04-18 | 1054.93x |
| 2018-04-17 | 1077.85x |
| 2018-04-16 | 1013.23x |
Showing the most recent 260 of 409 data points. The chart above shows the full history.
